A novel prognostic risk model for patients with refractory/relapsed acute myeloid leukemia receiving venetoclax plus hypomethylating agents
一种用于接受维奈托克联合去甲基化药物治疗的难治性/复发性急性髓系白血病患者的新型预后风险模型
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-024-02501-6
Shahswar, Rabia; Gabdoulline, Razif; Krueger, Katja; Wichmann, Martin; Götze, Katharina S; Braitsch, Krischan; Meggendorfer, Manja; Schmalbrock, Laura; Bullinger, Lars; Modemann, Franziska; Fiedler, Walter; Krauter, Juergen; Kaun, Stephan; Rotermund, Susanne; Voß, Andreas; Behrens, Yvonne Lisa; Bergmann, Anke Katharina; Koller, Elisabeth; Beutel, Gernot; Thol, Felicitas; Heidel, Florian; Heuser, Michael